Mirabegron
13 NDCs across 3 manufacturers|8 Generic,5 Brand
Mirabegron is used to treat overactive urinary bladder and urge urinary incontinence, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Jun 28, 2012, and the first generic was approved Dec 27, 2019. FDA's Orange Book lists 16 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $2.4 billion on Mirabegron across 3.7 million claims for 882,000 beneficiaries.
Mirabegron is available as 13 NDCs from 3 manufacturers (8 generic, 5 brand), with NADAC prices from $9.40 to $14.70 per EA — a 56% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
13
8G / 5B
Manufacturers
3
competing in market
Price Spread
$9.40 – $14.70
per EA, 12 of 13 NDCs
7d Activity
avg +0.1% WoW · of 13 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
3 manufacturers producing MIRABEGRON
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
MYRBETRIQ ER 50 MG TABLET | $14.6988 per EA | +0.05% |
MYRBETRIQ ER 50 MG TABLET | $14.6988 per EA | +0.05% |
MYRBETRIQ ER 25 MG TABLET | $14.6791 per EA | -0.01% |
MYRBETRIQ ER 25 MG TABLET | $14.6791 per EA | -0.01% |
MIRABEGRON ER 50 MG TABLET | $9.5960 per EA | -0.32% |
MIRABEGRON ER 50 MG TABLET | $9.5960 per EA | -0.32% |
MIRABEGRON ER 50 MG TABLET | $9.5960 per EA | -0.32% |
MIRABEGRON ER 50 MG TABLET | $9.5960 per EA | -0.32% |
MIRABEGRON ER 25 MG TABLET | $9.3992 per EA | +0.73% |
MIRABEGRON ER 25 MG TABLET | $9.3992 per EA | +0.73% |
MIRABEGRON ER 25 MG TABLET | $9.3992 per EA | +0.73% |
MIRABEGRON ER 25 MG TABLET | $9.3992 per EA | +0.73% |
MYRBETRIQ ER 8 MG/ML SUSP | $2.2069 per ML | 0.00% |
Frequently Asked Questions
What is Mirabegron used to treat?
Mirabegron is used to treat overactive urinary bladder and urge urinary incontinence, per the National Library of Medicine's MED-RT classification.
When did Mirabegron become available as a generic?
FDA approved the first generic Mirabegron (ANDA) on Dec 27, 2019. The Orange Book currently lists 16 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Mirabegron?
In 2024, Medicare Part D spent $2.4 billion on Mirabegron across 3.7 million claims for 882,000 beneficiaries.
How many Mirabegron products are on the market?
The Mirabegron drug market contains 13 NDCs from 3 manufacturers — 8 generic and 5 brand products.
What is the price range for Mirabegron?
NADAC reference prices for Mirabegron range from $9.3992 to $14.6988 per EA — a 56% difference between cheapest and most expensive. 1 additional product is priced per a different unit (e.g. liquids per ML) and isn't directly comparable.
Is generic Mirabegron cheaper than brand?
The average generic NADAC for Mirabegron is $9.4976 per EA, versus $14.6890 for brand-labeled products — generic is about 35% cheaper on average.
Which manufacturers make Mirabegron?
3 manufacturers list Mirabegron in NADAC. Ranked by number of NDCs, the largest are Astellas Pharma US, Inc. (5), Zydus Pharmaceuticals (USA) Inc. (4), Lupin Pharmaceuticals Inc. (4).
How has the price of Mirabegron changed recently?
Over the past 7 days, 6 Mirabegron NDCs rose and 6 fell, with a market-wide average change of +0.1%.